IVA vs OBX: stock comparison and AI forecast
Inventiva S.A. (IVA) and Obsidian Therapeutics, Inc. (OBX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IVA Inventiva S.A.
- Market Cap
- $896M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
OBX Obsidian Therapeutics, Inc.
- Market Cap
- $857M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- IVA and OBX have similar market capitalizations ($896M and $857M).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IVA | OBX |
|---|---|---|
| Market Cap | $896M | $857M |
| Revenue/Share | $0.09 | – |
Profitability & Margins
| Metric | IVA | OBX |
|---|---|---|
| Operating Margin | -1040.1% | – |
| Net Margin | -1034.0% | – |
Financial Health
| Metric | IVA | OBX |
|---|---|---|
| Current Ratio | – | 2.30x |
| Working Capital | – | $26M |
Cash Flow
| Metric | IVA | OBX |
|---|---|---|
| Operating Cash Flow | -$182M | – |
Income Statement
| Metric | IVA | OBX |
|---|---|---|
| Total Revenue | $20M | – |
| Operating Income | -$210M | – |
| Net Income | -$209M | – |
| R&D Expense | $202M | – |
Dividend & Shareholder Information
| Metric | IVA | OBX |
|---|---|---|
| Shares Outstanding | 236M | 62M |
IVA vs OBX: stock comparison and AI forecast
Which is bigger, IVA or OBX?
IVA and OBX have similar market capitalizations ($896M and $857M).
Which one does Intratio's AI model rank higher, IVA or OBX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.